| St Francis Hospice 24 Puiwa Road, Honolulu, HI, 96817 | |
| (808) 595-7566 |
News Archive
Radio frequency identification, RFID, could be used in the immediate aftermath of a major earthquake to save lives, according to new research published in the International Journal of Innovation and Sustainable Development.
A team led by scientists at The Scripps Research Institute has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States
As scientists uncover the precise molecular mechanisms that underlie effective cancer treatments, they gain invaluable insight into why predominantly successful treatments fail for some patients.
› Verified 6 days ago
| Name | St Francis Hospice |
|---|---|
| Location | 24 Puiwa Road, Honolulu, Hawaii |
| Hospice ID | 121500 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Church |
| Profit Type | NON-PROFIT |
| SSA county code | 020 |
News Archive
Radio frequency identification, RFID, could be used in the immediate aftermath of a major earthquake to save lives, according to new research published in the International Journal of Innovation and Sustainable Development.
A team led by scientists at The Scripps Research Institute has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States
As scientists uncover the precise molecular mechanisms that underlie effective cancer treatments, they gain invaluable insight into why predominantly successful treatments fail for some patients.
› Verified 6 days ago
| NPI Number | 1215948914 |
| Organization Name | St. Francis Community Health Services |
| Address | 24 Puiwa Rd Honolulu, Hawaii, 96817 |
| Phone Number | (808)595-7566 |
News Archive
Radio frequency identification, RFID, could be used in the immediate aftermath of a major earthquake to save lives, according to new research published in the International Journal of Innovation and Sustainable Development.
A team led by scientists at The Scripps Research Institute has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States
As scientists uncover the precise molecular mechanisms that underlie effective cancer treatments, they gain invaluable insight into why predominantly successful treatments fail for some patients.
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.9 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 97.3 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 99.3 | 93.3 |
News Archive
Radio frequency identification, RFID, could be used in the immediate aftermath of a major earthquake to save lives, according to new research published in the International Journal of Innovation and Sustainable Development.
A team led by scientists at The Scripps Research Institute has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States
As scientists uncover the precise molecular mechanisms that underlie effective cancer treatments, they gain invaluable insight into why predominantly successful treatments fail for some patients.
› Verified 6 days ago
| Home Health Aides | 15 |
| Counselors | 5 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 17 |
| Physicians | 3 |
| Registered Nurses | 40 |
| Other Personnel | 11 |
| Total Employees | 92 |
|---|
News Archive
Radio frequency identification, RFID, could be used in the immediate aftermath of a major earthquake to save lives, according to new research published in the International Journal of Innovation and Sustainable Development.
A team led by scientists at The Scripps Research Institute has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States
As scientists uncover the precise molecular mechanisms that underlie effective cancer treatments, they gain invaluable insight into why predominantly successful treatments fail for some patients.
› Verified 6 days ago
| St Francis Hospice Location: 24 Puiwa Road, Honolulu, Hawaii, 96817 Phone: (808) 595-7566 |
| Hospice Hawaii Location: 860 Iwilei Rd, Honolulu, Hawaii, 96817 Phone: (808) 595-7566 |
| Bristol Hospice - Hawaii, Llc Location: 500 Ala Moana Boulevard, Suite 4-545 And 547, Honolulu, Hawaii, 96813 Phone: (808) 595-7566 |
| Islands Hospice Location: 1301 Young St, Honolulu, Hawaii, 96814 Phone: (808) 595-7566 |